PCN Insights, News, Videos, and More

Task-based functional connectivity can serve as a biomarker for attention-deficit/hyperactivity disorder (ADHD), according to a study published online in Frontiers in Physiology.

A postmortem analysis of male patients revealed differences in the brains of those who had depression and died by suicide, compared with those who had no psychiatric disorders and died suddenly from other causes.

Nova Mentis Life Science Corp. recently announced that it has begun the diagnostic and treatment phase of an ongoing preclinical model study of autism spectrum disorder in which pregnant rats are exposed to valproic acid and the resultant...

BLOG: Late in the summer of 2020, I began to notice a pattern among my patients. Those patients who had become ill with COVID-19, the illness caused by the SARS-CoV-2 virus, were showing some similarities.

Clozapine was 4 times more likely than haloperidol to reduce violence in patients with schizophrenia and conduct disorder, a study published in The American Journal of Psychiatry found.

ED visit rates in the US for mental health conditions, suicide attempts, overdoses, intimate partner violence, and child abuse and neglect were higher during the first 6 months of the COVID-19 pandemic compared to last year.

Supernus Pharmaceuticals, Inc. has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration for approval of SPN-812 for pediatric attention deficit/hyperactivity disorder (ADHD).

The Multidisciplinary Association for Psychedelic Studies (MAPS) and Fireside Project, a not-for-profit psychedelic support services organization, on Monday announced plans to launch a national support line to help individuals having...